Important
Eli Lilly says its diabetes drug tirzepatide gets approval in China
Eli Lilly LLY said on Tuesday its tirzepatide drug has received approval from Chinese regulators for use to treat type 2 diabetes.
Tirzepatide is the active ingredient in the U.S. firm's diabetes drug Mounjaro and weight-loss drug Zepbound.